Enliven Therapeutics, Inc.
Insider Ownership
| 8-K | 34 | 11/13/2024 | 11/13/2024 |
| 8-K | 34 | 06/18/2024 | 06/18/2024 |
| 8-K/A | 34 | 05/29/2024 | 04/08/2024 |
| 10-Q | 34 | 05/14/2024 | 03/31/2024 |
| 8-K | 34 | 05/14/2024 | 05/14/2024 |
| 8-K | 34 | 04/11/2024 | 04/11/2024 |
| 8-K | 34 | 04/09/2024 | 04/08/2024 |
| 8-K | 34 | 03/19/2024 | 03/19/2024 |
| 10-K | 34 | 03/14/2024 | 12/31/2023 |
| 8-K | 34 | 03/14/2024 | 03/14/2024 |
≥5% Ownership
| 4 | 04/23/2025 | 04/21/2025 | |
| 4 | 04/21/2025 | 04/17/2025 | |
| 4 | 04/09/2025 | 04/07/2025 | |
| 4 | 03/31/2025 | 03/27/2025 | |
| 4 | 03/26/2025 | 03/24/2025 | |
| 4 | 03/21/2025 | 03/19/2025 | |
| 4 | 03/19/2025 | 03/17/2025 | |
| 4 | 03/06/2025 | 03/04/2025 | |
| 4 | 03/03/2025 | 02/27/2025 | |
| 4 | 02/10/2025 | 02/06/2025 |